Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
|Active Ingredient:||Denosumab 120mg|
|Dosage Form:||Solution for injection|
|New Zealand Sponsor:||Amgen New Zealand Limited|
|Manufacturers:||Amgen Manufacturing Limited, Juncos, Puerto Rico
Amgen Technology (Ireland) Unlimited Company, Dun Laoghaire, Ireland
Dated this 25th day of June 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).